The warning signs of what would become a deadly opioid epidemic emerged in early 2001. That’s when officials of the state employee health plan in West Virginia noticed a surge in deaths attributed to oxycodone, the active ingredient in the painkiller OxyContin

Quick Read

Another pharmaceutical company is coming under fire for boosting the price of one of its drugs. Two lawmakers are demanding to know the justification for a more than $80,000 price hike for a year’s supply of a drug that treats leukemia patients

Quick Read

And don’t seem to care that we don’t know who officially owns CRISPR. A Swiss startup hoping to harness the gene-editing technology it’s named after to develop treatments for genetic illnesses like sickle-cell anemia and cystic fibrosis—went public today (Oct. 19), raising $56 million in its initial public offering

Quick Read

But their prices are widening the health gap. Touted benefits can be realized only if those with chronic conditions have access to the technologies aimed at helping them. There is a gap between those who would receive the greatest benefit from using digital health technologies and those who actually have access to them

Quick Read

Drug Coupons

October 13, 2016

Helping a few at the expense of everyone. When a furor erupted over the rapidly rising price of EpiPens this summer, the drugmaker Mylan offered a solution: a coupon for the expensive drug. People who need the EpiPens to protect themselves from life-threatening allergic reactions could use the coupon to get up to $300 off at the pharmacy counter if their insurance plan has a deductible or a co-payment

Quick Read

Salvatore Chimenti already had advanced liver damage from the hepatitis C virus when he filed a lawsuit against the Pennsylvania Department of Corrections in the summer of 2015. He wanted access to new and expensive drugs that cure the virus in 90 percent or more of people who take them

Quick Read

Inpatient drug spending increased by 23.4 percent annually from 2013 to 2015, compared with 9.9 percent annual increases on retail drug spending during the same period, according to a new report

Quick Read

While critics emphasize the ACA’s shortcomings, cost and quality issues have long plagued the U.S. health care system. As my research demonstrates, we have these problems because insurance companies are at the center of the system, where they both finance and manage medical care. If this system is so flawed, how did we get stuck with it in the first place?

Quick Read